No press releases found.
(Exclusive) PRO Biotech Letter: Market Dislocation, Gilead, Corona-Portunities
Seeking Alpha (Sun, 7-Feb 2:28 AM ET)
Top 10 ETFs with cheapest skew - Barclays
Seeking Alpha News (Thu, 9-May 2:14 PM ET)
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry.
iShares Biotechnology ETF trades on the NASDAQ stock market under the symbol IBB.
As of May 13, 2024, IBB stock price climbed to $134.32 with 1,047,595 million shares trading.
IBB has a beta of 1.00, meaning it tends to be less sensitive to market movements. IBB has a correlation of 0.52 to the broad based SPY ETF.
IBB has a market cap of $7.05 billion. This is considered a Mid Cap stock.
In the last 3 years, IBB stock traded as high as $177.37 and as low as $104.29.
IBB has underperformed the market in the last year with a return of +2.8%, while the SPY ETF gained +27.8%. In the last 3 month period, IBB fell short of the market, returning -0.1%, while SPY returned +4.2%. However, in the most recent 2 weeks IBB has outperformed the stock market by returning +6.2%, while SPY returned +2.5%.
IBB support price is $131.92 and resistance is $134.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBB stock will trade within this expected range on the day.